SAN DIEGO - May 23, 2017 - Nucelis and Cibus have entered into a partnership agreement with Fermic to develop fermentation and associated downstream manufacturing processes aimed at the commercialization of naturally-sourced specialty ingredients for the food and personal care markets.Based in San Diego, Nucelis and Cibus are affiliate companies of Cibus Global, an innovative biotechnology company deploying its proprietary and powerful trait development platform, including its non-transgenic approaches, in both plants and microorganisms. Cibus has commercialized its first product, SU Canola™, in North Dakota and other U.S. states. Nucelis is leveraging the platform broadly in microorganisms to generate sustainably-sourced high value specialty ingredients for the food, flavor and fragrance, and personal care markets.“We are very pleased to announce this agreement today and delighted to be working with a prestigious partner like Fermic,” said Sean O’Connor, Ph.D., President and CEO of Nucelis. “This partnership combines Cibus’ unique technology platform with Fermic’s extensive fermentation manufacturing capabilities and commercialization experience. Together we plan on developing and launching a range of specialty ingredients for the food and cosmetic industries. Our first product is vitamin D2 with which we plan to help meet the growing demand for this sustainable and vegan form of vitamin D.”Fermic, a renowned fermentation-based manufacturer headquartered in Mexico City, is a longstanding producer and seller of antibiotics and other pharmaceutical actives ingredients. Fermic also provides toll production and process development services to many customers in several key industrial biotechnology markets. “As Nucelis and Fermic work together to commercialize ingredient solutions for these high-demand markets, we plan to meet the needs of consumers who want the food they eat and personal care products they use to be natural and sustainable,” said Alessandro Falzoni, CEO of Fermic.For more information or to schedule an interview with a Nucelis representative, please contact Shawna McGregor at 917-971-7852 or shawna@rosengrouppr.com.

ABOUT CIBUS AND NUCELIS

Cibus develops novel characteristics across a broad range of organisms. The company has a worldwide presence, with subsidiaries in both Europe and North America and a state-of-the-art research and development center in San Diego, California. In crops, we are accelerating plant breeding, offering our first commercial product, SU Canola™, and building a full pipeline of crops featuring beneficial characteristics, including healthier oil profiles, disease resistance and drought tolerance, scheduled for commercialization over the next decade. Nucelis, a wholly-owned subsidiary of Cibus, is expected to launch its naturally sourced vitamin D2 and squalane in 2018. Nucelis uses Cibus' RTDS platform to develop novel characteristics across a broad range of organisms, and is developing additional high value, sustainable products across a broad range of microbial platforms for the food, flavor and fragrance and personal care markets. Cibus’ core purpose is to lead the transition to sustainable non-transgenic agricultural and industrial products and improved human health by harvesting nature’s diversity. For more information, visit cibus.com. Find Cibus on LinkedIn, Twitter, Instagram, Facebook and Google+.